In last trading session, Humacyte Inc (NASDAQ:HUMA) saw 2.26 million shares changing hands with its beta currently measuring 1.96. Company’s recent per share price level of $2.22 trading at $0.03 or 1.37% at ring of the bell on the day assigns it a market valuation of $344.36M. That closing price of HUMA’s stock is at a discount of -340.99% from its 52-week high price of $9.79 and is indicating a premium of 48.2% from its 52-week low price of $1.15.
For Humacyte Inc (HUMA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.29. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Humacyte Inc (NASDAQ:HUMA) trade information
Upright in the green during last session for gaining 1.37%, in the last five days HUMA remained trading in the red while hitting it’s week-highest on Friday, 06/20/25 when the stock touched $2.22 price level, adding 7.5% to its value on the day. Humacyte Inc’s shares saw a change of -56.47% in year-to-date performance and have moved -5.93% in past 5-day. Humacyte Inc (NASDAQ:HUMA) showed a performance of -10.48% in past 30-days.
Wall Street analysts have assigned a consensus price target of 6 to the stock, which implies a rise of 63.0% to its current value. Analysts have been projecting 5 as a low price target for the stock while placing it at a high target of 10. It follows that stock’s current price would drop -125.23% in reaching the projected high whereas dropping to the targeted low would mean a loss of -125.23% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 42.43% during past 5 years.
Humacyte Inc (NASDAQ:HUMA)’s Major holders
BLACKROCK INC. is the top institutional holder at HUMA for having 7.14 million shares of worth $34.27 million. And as of 2024-06-30, it was holding 5.9912 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 4.73 million shares on 2024-06-30. The number of shares represents firm’s hold over 3.9686 of outstanding shares, having a total worth of $22.7 million.
